Radiology

Covera Health Expands Radiology Centers of Excellence to Include Prostate MRI, Enhancing Nation’s Leading Imaging Quality Program

Significant expansion of Covera’s proven COE platform launching in 2026; provider applications now open, with employer and health plan partners preparing for deployment NEW YORK, May 8, 2025 /PRNewswire/ — Covera Health, a market leader in radiology quality, today announced a major…

Akumin Appoints Chief Medical Officer

PLANTATION, Fla., May 6, 2025 /PRNewswire/ – Akumin, a leader in managed radiology and oncology services, is pleased to announce the appointment of Dr. Nasir Siddiqui as Chief Medical Officer (CMO). As Chief Medical Officer, Dr. Siddiqui will lead Akumin’s clinical strategic priorities…

Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer

QUEENSBURY, N.Y.–(BUSINESS WIRE)–Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the U.S. Food and Drug Administration (FDA) has completed its 30-day review of the Company’s Investigational New Drug (IND) application for a Phase 2 clinical trial […]

HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials

MINNEAPOLIS–(BUSINESS WIRE)–HistoSonics, the developer of the Edison Histotripsy System, announced today 12-month follow-up clinical data from its prospective #HOPE4LIVER trials, designed to evaluate the safety and efficacy of histotripsy for the non-invasive destruction of primary (hepatocellular cancer-HCC) and metastatic liver tumors. “The one-year outcome data for the HOPE4LIVER trial are […]